ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
64,033.06
0.22%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Canadá
  5. TSXV
  6. Intelgenx Technologies Corp (IGX)

  7. Intelgenx Technologies Corp (IGX) Noticias

IGX

Intelgenx Technologies (IGX)

Intelgenx Technologies Corp
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:TSXV:IGX
FechaHoraFuenteTítuloSímboloCompañía
27/03/202010:54PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - IGXTSXV:IGXIntelgenx Technologies Corp
27/03/202010:52PR Newswire (Canada)IIROC Trading Resumption - IGXTSXV:IGXIntelgenx Technologies Corp
27/03/202009:04PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - Enter Symbol(s) HereTSXV:IGXIntelgenx Technologies Corp
27/03/202009:02PR Newswire (Canada)IIROC Trading Halt - IGXTSXV:IGXIntelgenx Technologies Corp
19/12/201915:32PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - IGXTSXV:IGXIntelgenx Technologies Corp
18/10/201809:08PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - IGX ; IGX.DBTSXV:IGXIntelgenx Technologies Corp
18/10/201809:07PR Newswire (Canada)IIROC Trading Resumption - IGX; IGX.DBTSXV:IGXIntelgenx Technologies Corp
17/10/201815:31PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - IGX, IGX.DBTSXV:IGXIntelgenx Technologies Corp
17/10/201815:28PR Newswire (Canada)IIROC Trading Halt - IGX, IGX.DBTSXV:IGXIntelgenx Technologies Corp
05/12/201708:53PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - IGX; IGX.DBTSXV:IGXIntelgenx Technologies Corp
05/12/201708:27PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - IGX IGX.DBTSXV:IGXIntelgenx Technologies Corp
05/12/201708:24PR Newswire (Canada)IIROC Trading Halt - IGX IGX.DBTSXV:IGXIntelgenx Technologies Corp
15/11/201107:16MarketwiredSpeculative Healthcare Companies IntelGenx and Adventrx Begin to Gain GroundTSXV:IGXIntelgenx Technologies Corp
09/08/201105:00MarketwiredIntelGenx Reports Q2, 2011 Results and Highlights Recent DevelopmentsTSXV:IGXIntelgenx Technologies Corp
02/08/201105:00MarketwiredIntelGenx Announces Successful Pre-Approval Inspection of its Lead Product CPI-300TSXV:IGXIntelgenx Technologies Corp
22/06/201109:35MarketwiredIntelGenx Announces Closing of Private PlacementsTSXV:IGXIntelgenx Technologies Corp
14/06/201111:36MarketwiredIntelGenx Announces Licensing of Anti-Psychotic VersaFilm ProductTSXV:IGXIntelgenx Technologies Corp
14/06/201105:00MarketwiredIntelGenx Announces New PDUFA Date for Its Single Dose 450 mg Bupropion Hydrochloride TabletTSXV:IGXIntelgenx Technologies Corp
03/06/201108:45MarketwiredIntelGenx Announces Up to Approximately US$3 Million Equity Offering of Common Stock and WarrantsTSXV:IGXIntelgenx Technologies Corp
24/05/201105:00MarketwiredIntelGenx Welcomes Dr. Rajiv Khosla to Its BoardTSXV:IGXIntelgenx Technologies Corp
16/05/201105:00MarketwiredIntelGenx Submits Reply to FDA Complete Response Letter for its Single Dose 450 mg Bupropion Hydrochloride TabletTSXV:IGXIntelgenx Technologies Corp
11/05/201105:00MarketwiredIntelGenx Reports Q1, 2011 Results and Highlights Recent DevelopmentsTSXV:IGXIntelgenx Technologies Corp
06/04/201105:00MarketwiredIntelGenx Completes Positive Bioequivalence Study with Insomnia Thin FilmTSXV:IGXIntelgenx Technologies Corp
30/03/201105:00MarketwiredIntelGenx Reports 2010 Financial Results and Summarizes Key DevelopmentsTSXV:IGXIntelgenx Technologies Corp
04/03/201113:36MarketwiredIntelGenx Announces Departure of DirectorTSXV:IGXIntelgenx Technologies Corp
07/02/201105:00MarketwiredIntelGenx Achieves Positive Bioequivalence Results for a Leading Branded Anti-Psychotic Using VersaFilm Oral Thin Film TechnologTSXV:IGXIntelgenx Technologies Corp
03/02/201105:00MarketwiredIntelGenx Announces Dismissal of Patent Litigation Relating to Its Once Daily High Dose 450 mg Bupropion Hydrochloride TabletTSXV:IGXIntelgenx Technologies Corp
05/01/201105:00MarketwiredIntelGenx to Present at OneMedForum Conference in San FranciscoTSXV:IGXIntelgenx Technologies Corp
04/01/201105:00MarketwiredIntelGenx Receives Positive Ruling in Patent Litigation HearingTSXV:IGXIntelgenx Technologies Corp
29/11/201005:00MarketwiredIntelGenx Acquires Full Ownership and Exclusive Rights to MS Induced Pain ProductTSXV:IGXIntelgenx Technologies Corp
 Showing the most relevant articles for your search:TSXV:IGX

Su Consulta Reciente

CCOM
SILVER
SILVER
SPI
SP500
S&P 500
USI
USTECH100
US Tech 100
NASDAQ
MSFT
Microsoft
NYSE
DIS
Walt Disney
PM
XAUUSD
Gold vs US Dollar
CCOM
OILBRENT
Brent Oil
USOTC
DTEGY
Deutsche Telekom (QX)
COIN
BTCUSD
Bitcoin
NASDAQ
AAPL
Apple
AMEX
XLV
Health Care Select Sector
FX
EURMXN
Euro vs MXN
USOTC
BASFY
BASF (QX)
NYSE
JPM
JP Morgan Chase
NYSE
XOM
Exxon Mobil
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados